Prime Medicine Inc (NASDAQ:PRME) traded at $4.29 at close of the session on Tuesday, July 15 and made a downward move of -10.72% on its previous day’s price.
Looking at the stock we see that its previous close was $4.8 and the beta (5Y monthly) reads 1.547 with the day’s price range being $4.24 – $5.0. In terms of its 52-week price range, PRME has a high of $6.75 and a low of $1.11. The company’s stock has gained about 193.84% over that past 30 days.
Prime Medicine Inc has a market cap of $563.25 million and is expected to release its quarterly earnings report on 2025-May-08.
On the other hand, looking at the outlook for the PRME stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of Hold.
Based on estimates by 5 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 1 have rated the Prime Medicine Inc (PRME) stock as a Hold, while 4 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 40.54% off its SMA20 and 110.14% from its 50-day simple moving average. The RSI (14) is pointing at 69.86 while the volatility over the past week is 15.59% and jumps to 15.80% over the past one month. The average price target for the stock over the next 12 months is $17, with the estimates having a low of $12 and a high of $23. These price ends are -179.72% and -436.13% off the current price level respectively, although investors could be excited at the prospect of a -296.27% if the PRME share price touches on the median price of $17.
Coming back to Prime Medicine Inc (NASDAQ:PRME), we note that the average 3-month trading volume was 3.13 million, while that of the preceding 10-day period stands at 6.41 million. Current shares outstanding are 131.16 million.
The insiders hold 60.67% of the company’s shares while institutions hold 28.97%. The data shows that short shares as of 2025-06-13, stood at 18.48 million at a short ratio of 7.36. This represents a 2726.00 short interest in shares outstanding on 2025-06-13. Shares short rose in June from the previous month at 17.7 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -28.50% down in year-to-date price movement.
